BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1357 related articles for article (PubMed ID: 25898891)

  • 1. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study.
    Strobl FF; Rominger A; Wolpers S; Rist C; Bamberg F; Thierfelder KM; Nikolaou K; Uebleis C; Hacker M; Reiser MF; Saam T
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1899-908. PubMed ID: 23979062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.
    Pasha AK; Moghbel M; Saboury B; Gharavi MH; Blomberg BA; Torigian DA; Kwee TC; Basu S; Mohler Iii ER; Alavi A
    Hell J Nucl Med; 2015; 18(1):5-10. PubMed ID: 25679072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point
    Kang MK; Kim CJ; Choo EH; Han EJ; Hwang BH; Kim JJ; Kim SH; O JH; Chang K
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake.
    Liu J; Kerwin WS; Caldwell JH; Ferguson MS; Hippe DS; Alessio AM; Martinez-Malo V; Pimentel K; Miyaoka RS; Kohler TR; Hatsukami TS; Yuan C
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):145-52. PubMed ID: 26280889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should vascular wall
    Lensen KDF; Voskuyl AE; Comans EFI; van der Laken CJ; Boellaard R; Smulders YM
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):545-551. PubMed ID: 31898005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
    Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
    JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
    Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
    Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation.
    Gorla R; Erbel R; Kuehl H; Kahlert P; Tsagakis K; Jakob H; Mahabadi AA; Schlosser T; Bockisch A; Eggebrecht H; Bossone E; Jánosi RA
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1677-85. PubMed ID: 26220267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
    Rominger A; Saam T; Wolpers S; Cyran CC; Schmidt M; Foerster S; Nikolaou K; Reiser MF; Bartenstein P; Hacker M
    J Nucl Med; 2009 Oct; 50(10):1611-20. PubMed ID: 19759117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
    Mizoguchi M; Tahara N; Tahara A; Nitta Y; Kodama N; Oba T; Mawatari K; Yasukawa H; Kaida H; Ishibashi M; Hayabuchi N; Harada H; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1110-8. PubMed ID: 21999871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
    Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S
    J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
    Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM
    Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
    Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
    Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
    Silvera SS; Aidi HE; Rudd JH; Mani V; Yang L; Farkouh M; Fuster V; Fayad ZA
    Atherosclerosis; 2009 Nov; 207(1):139-43. PubMed ID: 19467659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
    Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA
    Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.